Spirit of America Management Corp NY lowered its stake in UnitedHealth Group Inc (NYSE:UNH) by 19.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,650 shares of the healthcare conglomerate’s stock after selling 1,350 shares during the quarter. Spirit of America Management Corp NY’s holdings in UnitedHealth Group were worth $1,666,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of UNH. Country Trust Bank boosted its position in shares of UnitedHealth Group by 556.3% during the 1st quarter. Country Trust Bank now owns 105 shares of the healthcare conglomerate’s stock valued at $26,000 after acquiring an additional 89 shares during the last quarter. RMR Wealth Builders bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $29,000. Lion Street Advisors LLC bought a new stake in shares of UnitedHealth Group during the 1st quarter valued at about $31,000. Total Clarity Wealth Management Inc. bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $34,000. Finally, Beutel Goodman & Co Ltd. bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $36,000. Hedge funds and other institutional investors own 86.59% of the company’s stock.

In other UnitedHealth Group news, Director Stephen J. Hemsley sold 45,637 shares of the stock in a transaction on Monday, May 11th. The shares were sold at an average price of $289.11, for a total transaction of $13,194,113.07. Following the completion of the sale, the director now owns 1,013,122 shares of the company’s stock, valued at approximately $292,903,701.42. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.80% of the company’s stock.

UNH traded down $0.40 during trading on Friday, hitting $290.76. 964,873 shares of the stock traded hands, compared to its average volume of 3,260,356. The firm has a market capitalization of $276.13 billion, a P/E ratio of 20.34, a price-to-earnings-growth ratio of 1.47 and a beta of 0.72. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.75 and a quick ratio of 0.75. The firm has a 50-day moving average of $296.27 and a 200 day moving average of $282.78. UnitedHealth Group Inc has a 12-month low of $187.72 and a 12-month high of $315.84.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Wednesday, April 15th. The healthcare conglomerate reported $3.72 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $3.63 by $0.09. The business had revenue of $64.40 billion during the quarter, compared to analysts’ expectations of $64.25 billion. UnitedHealth Group had a net margin of 5.59% and a return on equity of 24.86%. The firm’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.73 EPS. As a group, equities analysts predict that UnitedHealth Group Inc will post 16.27 EPS for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Monday, June 22nd were given a dividend of $1.25 per share. The ex-dividend date was Friday, June 19th. This represents a $5.00 annualized dividend and a yield of 1.72%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.08. UnitedHealth Group’s dividend payout ratio is presently 33.09%.

UNH has been the subject of a number of research analyst reports. Stephens lifted their price target on UnitedHealth Group from $310.00 to $325.00 and gave the company an “overweight” rating in a research report on Tuesday, June 2nd. Cowen lifted their price target on UnitedHealth Group from $320.00 to $340.00 and gave the company an “outperform” rating in a research report on Thursday, April 16th. Barclays reiterated a “buy” rating and set a $322.00 price target on shares of UnitedHealth Group in a research report on Sunday, March 29th. ValuEngine lowered UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday, July 2nd. Finally, Morgan Stanley increased their price target on shares of UnitedHealth Group from $289.00 to $371.00 and gave the company an “overweight” rating in a research report on Thursday, April 30th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and twenty-two have given a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $328.42.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Article: Management Fee

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.